Cargando…

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates

We evaluated the association between 16S rRNA gene (rrs) mutations and susceptibility in clinical isolates of amikacin-resistant nontuberculous mycobacteria (NTM) in NTM-pulmonary disease (PD) patients. Susceptibility was retested for 134 amikacin-resistant isolates (minimum inhibitory concentration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Su-Young, Kim, Dae Hun, Moon, Seong Mi, Song, Ju Yeun, Huh, Hee Jae, Lee, Nam Yong, Shin, Sung Jae, Koh, Won-Jung, Jhun, Byung Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969740/ https://www.ncbi.nlm.nih.gov/pubmed/33731862 http://dx.doi.org/10.1038/s41598-021-85721-5

Ejemplares similares

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020)

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Desiccation-Tolerance of Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium chimaera, Mycobacterium abscessus and Mycobacterium chelonae
por: Falkinham, Joseph O., et al.
Publicado: (2022)

Amikacin liposome and Mycobacterium avium complex: A systematic review
por: Zangiabadian, Moein, et al.
Publicado: (2022)

Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease
por: Park, Youngmok, et al.
Publicado: (2021)

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea
por: Park, Sunghoon, et al.
Publicado: (2008)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
por: Kim, Seong Min, et al.
Publicado: (2023)

Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin
por: Yang, Jeng-How, et al.
Publicado: (2022)

Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series
por: Davis, Kala K, et al.
Publicado: (2007)

In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022)

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
por: Kumar, Kartik, et al.
Publicado: (2022)

Thin-Section CT Findings of Nontuberculous Mycobacterial Pulmonary Diseases: Comparison Between Mycobacterium avium-intracellulare Complex and Mycobacterium abscessus Infection
por: Chung, Myung Jin, et al.
Publicado: (2005)

Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection
por: Lee, Ju Mi, et al.
Publicado: (2023)

Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models
por: Zheng, Luyao, et al.
Publicado: (2023)

Diagnosis and Management of Pulmonary NTM with a Focus on Mycobacterium avium Complex and Mycobacterium abscessus: Challenges and Prospects
por: Hendrix, Christian, et al.
Publicado: (2022)

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Rifabutin Is Active against Mycobacterium abscessus in Mice
por: Dick, Thomas, et al.
Publicado: (2020)

Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
por: Kim, Bo-Guen, et al.
Publicado: (2022)

In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics
por: Shen, Yaojie, et al.
Publicado: (2018)

Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis
por: Li, Haoran, et al.
Publicado: (2022)

Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience
por: Chiron, Raphael, et al.
Publicado: (2022)

Characteristics of Circulating CD4(+) T Cell Subsets in Patients with Mycobacterium avium Complex Pulmonary Disease
por: Han, Sun Ae, et al.
Publicado: (2020)

Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

805. Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
por: Brown-Elliott, Barbara A, et al.
Publicado: (2018)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
por: Sohn, Sungmin, et al.
Publicado: (2017)

Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex
por: Nagano, Hiroaki, et al.
Publicado: (2022)

2148. In vitro Potency of a Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Against Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium abscessus
por: Shoen, Carolyn M, et al.
Publicado: (2023)

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
por: Henriette Zweijpfenning, Sanne Maria, et al.
Publicado: (2022)

Spontaneous Cultural Conversion Rate of Mycobacterium avium Complex Pulmonary Disease Based on BACES Severity
por: Kim, Bo-Guen, et al.
Publicado: (2023)

Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

The First Korean Case of Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium abscessus Subspecies bolletii in a Patient with Bronchiectasis
por: Jeong, Byeong-Ho, et al.
Publicado: (2014)

First Isolation of Mycobacterium virginiense From a Human Pulmonary Specimen
por: Jung, Jaewan, et al.
Publicado: (2019)

Canaliculitis por Mycobacterium abscessus subsp. abscessus
por: Tello, María Nieves Carmona, et al.
Publicado: (2021)

Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus
por: Born, Sarah E. M., et al.
Publicado: (2023)

Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
por: Hoy, Sheridan M.
Publicado: (2021)

Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease
por: Marras, Theodore K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jaakkahmbd1agim0u1ek5k48c8